Literature DB >> 1627256

Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease.

F Sherif1, C G Gottfries, I Alafuzoff, L Oreland.   

Abstract

Activities of Gamma-aminobutyrate aminotransferase (GABA-T) and Monoamine oxidase (MAO)-A and -B were estimated in postmortem brains from 6 control subjects without psychiatric or neurologic disorders and 8 histopathologically verified cases of patients with Alzheimer's disease and senile dementia of Alzheimer type (AD/SDAT). The enzyme activities were examined in four cortical brain regions, three nuclei in the basal ganglia, thalamus and white matter. GABA-T activities in the cortical regions (frontal, parietal, occipital and temporal cortices) and nucleus caudatus were significantly lowered in the AD/SDAT patients. The MAO-A activities were significantly increased in the occipital cortex, caudate nucleus, thalamus and white matter in the AD/SDAT patients. No significant differences were found in the other regions (frontal cortex, parietal cortex, temporal cortex, putamen and globus pallidus). The MAO-B activities in three cortical regions (frontal, parietal and occipital cortices), thalamus and white matter were significantly increased in the AD/SDAT patients, whereas no difference was apparent in the other regions. The changed activities could not be correlated with age or postmortem time. The present results are the first describing decreased GABA-T activities as well as increased MAO-A activities in brain from patients with AD/SDAT, while the results with MAO-B support previous findings. A possible connection was found between the order of magnitude of the changes in enzyme activities and the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627256     DOI: 10.1007/bf02260906

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  12 in total

1.  Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.

Authors:  Zelan Wei; Tamara Satram-Maharaj; Bradley Chaharyn; Kelly Kuski; Paul R Pennington; Xia Cao; Jennifer Chlan; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2012-03-03       Impact factor: 3.575

Review 2.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

3.  Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.

Authors:  Paul R Pennington; Zelan Wei; Lewei Rui; Jennifer A Doig; Brett Graham; Kelly Kuski; Geraldine G Gabriel; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

4.  Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.

Authors:  Nathan J Kolla; Lina Chiuccariello; Alan A Wilson; Sylvain Houle; Paul Links; R Michael Bagby; Shelley McMain; Charis Kellow; Jalpa Patel; Paraskevi V Rekkas; Suvercha Pasricha; Jeffrey H Meyer
Journal:  Biol Psychiatry       Date:  2014-12-16       Impact factor: 13.382

Review 5.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

6.  Increase in brain GABA-transaminase activity after chronic ethanol treatment in rats.

Authors:  F Sherif; G Wahlström; L Oreland
Journal:  J Neural Transm Gen Sect       Date:  1994

7.  Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy.

Authors:  Awanish Mishra; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2013-10-08       Impact factor: 3.996

8.  Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.

Authors:  Claudia Salcedo; Antonie Wagner; Jens V Andersen; Kasper Tore Vinten; Helle S Waagepetersen; Arne Schousboe; Kristine K Freude; Blanca I Aldana
Journal:  Neurochem Res       Date:  2021-03-12       Impact factor: 3.996

9.  Effects of different fatty acids composition of phosphatidylcholine on brain function of dementia mice induced by scopolamine.

Authors:  Miao-Miao Zhou; Yong Xue; Shu-Hong Sun; Min Wen; Zhao-Jie Li; Jie Xu; Jing-Feng Wang; Teruyoshi Yanagita; Yu-Ming Wang; Chang-Hu Xue
Journal:  Lipids Health Dis       Date:  2016-08-24       Impact factor: 3.876

10.  Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology.

Authors:  Xia Cao; Zelan Wei; Geraldine G Gabriel; XinMin Li; Darrell D Mousseau
Journal:  BMC Neurosci       Date:  2007-09-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.